Close Menu

NEW YORK (GenomeWeb) – Having just secured its second small business grant from the National Institutes of Health, University at Albany spinout Hocus Locus is aiming to further develop a novel microRNA inhibition technology initially for research applications and, ultimately, as a therapeutic modality.

The approach is based on so-called structurally interacting RNAs, or sxRNAs, which the company believes are part of a post-transcriptional regulatory mechanism that controls RNA binding protein (RBP) interactions with messenger RNA.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.